ZYUS Life Sciences Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 29, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	51	70	63	-	-	-
Market Cap Growth	-28.30%	11.19%	-	-	-	-
Enterprise Value	63	77	65	-	-	-
Last Close Price	0.65	0.94	0.90	-	-	-
PS Ratio	105.17	145.32	179.10	-	-	-
PB Ratio	-5.19	-13.08	2.72	-	-	-
P/TBV Ratio	-	-	12.77	-	-	-
EV/Sales Ratio	130.94	161.10	184.09	-	-	-
Debt / Equity Ratio	-1.33	-2.27	0.42	7.36	1.02	0.32
Asset Turnover	0.02	0.02	0.01	0.00	0.00	-
Inventory Turnover	1.11	1.08	0.76	0.20	0.01	-
Quick Ratio	0.07	0.13	0.49	0.03	0.11	1.35
Current Ratio	0.13	0.19	0.71	0.44	0.78	2.34
Return on Equity (ROE)	-1184.76%	-380.47%	-305.81%	-164.77%	-67.78%	-
Return on Assets (ROA)	-40.34%	-35.05%	-22.77%	-15.46%	-19.44%	-
Return on Capital (ROIC)	-66.38%	-49.66%	-33.37%	-23.08%	-26.09%	-
Earnings Yield	-67.01%	-48.37%	-67.75%	-	-	-
FCF Yield	-19.13%	-14.19%	-29.00%	-	-	-
Buyback Yield / Dilution	-5.21%	-28.41%	-45.82%	24.99%	-5.35%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.